Kevin Caliendo
Stock Analyst at UBS
(4.04)
# 556
Out of 5,124 analysts
197
Total ratings
64.42%
Success rate
7.49%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $96 → $97 | $80.70 | +20.20% | 11 | Dec 10, 2025 | |
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $83.16 | -5.00% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.28 | +37.36% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $346.17 | +19.88% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.90 | +37.93% | 8 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $826.51 | +18.57% | 17 | Nov 6, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $208.48 | +5.53% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $21.30 | -15.49% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $348.97 | +23.22% | 13 | Oct 29, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $325 → $320 | $260.40 | +22.89% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $12.37 | +85.93% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $184.73 | -7.97% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $180.46 | +5.29% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $167.66 | -7.55% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $78.55 | -10.88% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $23.21 | -5.21% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $4.02 | +273.13% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.33 | +68.86% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $284.76 | +36.96% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $279.84 | -10.66% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $45.74 | +72.72% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $371.37 | +54.83% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $204.79 | -12.11% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.00 | +800.00% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $32.11 | -65.74% | 4 | May 4, 2021 |
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $80.70
Upside: +20.20%
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $83.16
Upside: -5.00%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.28
Upside: +37.36%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $346.17
Upside: +19.88%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.90
Upside: +37.93%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $826.51
Upside: +18.57%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $208.48
Upside: +5.53%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $21.30
Upside: -15.49%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $348.97
Upside: +23.22%
Labcorp Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $260.40
Upside: +22.89%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $12.37
Upside: +85.93%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $184.73
Upside: -7.97%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $180.46
Upside: +5.29%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $167.66
Upside: -7.55%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $78.55
Upside: -10.88%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $23.21
Upside: -5.21%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $4.02
Upside: +273.13%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.33
Upside: +68.86%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $284.76
Upside: +36.96%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $279.84
Upside: -10.66%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $45.74
Upside: +72.72%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $371.37
Upside: +54.83%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $204.79
Upside: -12.11%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.00
Upside: +800.00%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $32.11
Upside: -65.74%